TuHURA Biosciences Inc. (HURA)
NASDAQ: HURA
· Real-Time Price · USD
3.90
0.00 (0.00%)
At close: May 02, 2025, 3:59 PM
3.92
0.38%
After-hours: May 02, 2025, 04:05 PM EDT
Company Description
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy.
The company is headquartered in Tampa, FL.
TuHURA Biosciences Inc.
| Country | United States |
| IPO Date | Feb 22, 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 19 |
| CEO | Dr. James A. Bianco M.D. |
Contact Details
Address: No Address available Tampa, United States | |
| Website | http://www.tuhurabio.com |
Stock Details
| Ticker Symbol | HURA |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | US8989201038 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. James A. Bianco M.D. | President, Chief Executive Officer & Director |
| Dan Dearborn CPA | Executive Vice President of Finance & Chief Financial Officer |
| Dr. Bertrand Le Bourdonnec Ph.D. | Executive Vice President, Head of Drug Discovery, Early Development, & Program Management |
| Michael Krsulich | Head of Quality Assurance |
| Michael Lawman | Co-Founder |
| Patricia Lawman | Co-Founder |